5Borbu VZC.Vitamin D deficiency in patients with active SLE[J].Osteoporosis Int,2009,20(3):427-433.
6American College of Rheumatology Ad Hoc Committee of Gluc-ocorticoid-Induced Osteoporosis.Recommendations for the preve-ntion and treatment of glucocorticoid-induced osteoporsis:2001update[J].Arthritis Rheum,2001,44(7):1496-1503.
2HotiekM F, Vitamin D. A nifllenium perspective [ J ]. J Cell Biochem,2003,88(2) :296-307.
3Chatfield SM, Brand C, Ebeling PR,et al. Vitamin D deficiency in general medical in patients in summer and winter [ J ]. Int Med J,2007,37 (6) :377-382.
6Ruiz-Irastorza G,Egurbide MV, Olivares N,et al. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences [ J ]. Rheumatology ,2008,47 (6) :920-923.
7Toloza SMA,Cole DEC, Gladman DD, et al. Vitamin D insufficiency in a large female SLE cohort[J]. Lupus,2009, 19( 1 ) :1-7.
8Borba VZC, Vitamin JD. Difieieney in patients with active SLE [ J]. Osteoporos Int ,2009,20 (3) :427-433.
9Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new etiological and therapeutical considerations [ J ]. Ann Rheum Dis,2007,66(9) :1137-1142.
2Ortega LM, Schultz DR, Lenz O, et al. Review: lupus nephritis:pathologic features, epidemiology and a guide to therapeuticdecisions[J]. Lupus, 2010, 19(5): 557-574.
3Yang Z, Liang Y, Xi W, et al. Association of serum uric acid withlupus nephritis in systemic lupus erythematosus[J]. Rheumatol Int,2011, 31(6): 743-748.
5Chen W, Chen W, Wang H, et al. Prevalence and risk factorsassociated with chronic kidney disease in an adult population fromsouthern China[J]. Nephrol Dial Transplant, 2009, 24(4): 1205-1212.
6Madero M, Sarnak MJ, Wang X, et al. Uric acid and long-termoutcomes in CKD[J]. Am J Kidney Dis, 2009, 53(5): 796-803.
7Obermayr RP, Temml C, Gutjahr G, et al. Elevated uric acid increasesthe risk for kidney disease[J]. J Am Soc Nephrol, 2008, 19(12):2407-2413.
8Ohno I. Relationship between hypertension and chronic kidneydiseases[J]. Nucleosides Nucleotides Nucleic Acids, 2011, 30(12):1039-1044.
9Jaramillo M, Godbout M, Naccache PH, et al. Signaling eventsinvolved in macrophage chemokine expression in response tomonosodium urate crystals[J]. J Biol Chem, 2004, 279(50):52797-52805.
10Liu N, Tolbert E, Ponnusamy M, et al. Delayed administration ofsuramin attenuates the progression of renal fibrosis in obstructivenephropathy[J]. J Pharmaeol Exp Ther, 2011, 338(3): 758-766.
